VSee Health, Inc. (VSEE)
VSee Health, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
VSee Health, Inc. (VSEE) is a Medical - Healthcare Information Services company based in US with a market capitalization of $3.1M. Revenue grew 40.3% year-over-year and free cash flow was negative at -$3.5M. This page tracks VSEE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 2 employees · IPO Dec 31, 2021
Valuation
Valuation & price
$0.18 · as of May 17, 2026 · -87.7% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.57
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$3.1M
Market cap
40.3%
Revenue growth (YoY)
50.3%
Gross margin
-$3.5M
Free cash flow (USD)
-$2.8M
Net debt
Net cash position
97.2%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2020 → 2025
Free cash flow by year
2020 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.05)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is VSee Health, Inc.'s market cap?
VSee Health, Inc. (VSEE) has a market capitalization of $3.1M.
What is VSEE's P/E ratio?
A meaningful P/E ratio is not available for VSEE — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is VSEE's price-to-book (P/B) ratio?
VSEE trades at 0.57 times book value per share.
When did VSee Health, Inc. last report earnings?
VSEE last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying VSEE stock?
SEC Form 4 filings show no open-market insider buys at VSee Health, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Healthcare Information Services
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.